Syndax Pharmaceuticals Inc (SNDX)
20.30
-0.62
(-2.96%)
USD |
NASDAQ |
May 17, 16:00
20.30
0.00 (0.00%)
After-Hours: 20:00
Syndax Pharmaceuticals Shares Outstanding: 84.99M for May 1, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
May 01, 2024 | 84.99M |
March 31, 2024 | 84.98M |
March 20, 2024 | 84.98M |
March 08, 2024 | 84.98M |
February 19, 2024 | 84.97M |
December 31, 2023 | 84.83M |
December 19, 2023 | 84.81M |
October 27, 2023 | 69.64M |
September 30, 2023 | 69.64M |
July 27, 2023 | 69.48M |
June 30, 2023 | 69.43M |
May 03, 2023 | 68.82M |
March 31, 2023 | 68.50M |
March 22, 2023 | 68.50M |
March 15, 2023 | 68.50M |
February 24, 2023 | 68.44M |
December 31, 2022 | 68.11M |
December 14, 2022 | 68.10M |
November 02, 2022 | 60.22M |
September 30, 2022 | 60.12M |
August 05, 2022 | 56.57M |
June 30, 2022 | 56.40M |
May 06, 2022 | 56.23M |
March 31, 2022 | 55.03M |
March 16, 2022 | 55.02M |
Date | Value |
---|---|
March 15, 2022 | 55.02M |
February 25, 2022 | 55.01M |
December 31, 2021 | 54.98M |
December 20, 2021 | 54.62M |
December 09, 2021 | 50.81M |
November 11, 2021 | 49.39M |
September 30, 2021 | 48.85M |
August 06, 2021 | 48.63M |
June 30, 2021 | 48.62M |
May 10, 2021 | 48.25M |
March 31, 2021 | 48.25M |
March 24, 2021 | 48.24M |
March 15, 2021 | 48.24M |
March 10, 2021 | 48.24M |
January 28, 2021 | 48.13M |
December 31, 2020 | 47.88M |
December 11, 2020 | 47.18M |
December 07, 2020 | 40.93M |
November 04, 2020 | 40.87M |
September 30, 2020 | 38.83M |
August 05, 2020 | 38.55M |
June 30, 2020 | 38.51M |
May 06, 2020 | 36.09M |
May 04, 2020 | 35.80M |
April 14, 2020 | 30.24M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
27.12M
Minimum
Jun 30 2019
84.99M
Maximum
May 01 2024
52.73M
Average
49.39M
Median
Nov 11 2021
Shares Outstanding Benchmarks
Geron Corp | 593.13M |
Verastem Inc | 25.33M |
Karyopharm Therapeutics Inc | 117.71M |
Crinetics Pharmaceuticals Inc | 78.86M |
Arvinas Inc | 68.43M |